Bellevue Life Sciences Warrant (OSRHW) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Bellevue Life Sciences Warrant (OSRHW:NASDAQ), powered by AI.

Current Price
$0.06
Sector
Healthcare
What is the Bellevue Life Sciences Warrant stock price forecast?

Bellevue Life Sciences Warrant is currently trading at $0.06. View real-time AI analysis on Alpha Lenz.

What is Bellevue Life Sciences Warrant insider trading activity?

View the latest insider trading data for Bellevue Life Sciences Warrant on Alpha Lenz.

What is Bellevue Life Sciences Warrant's P/E ratio?

View Bellevue Life Sciences Warrant's valuation metrics on Alpha Lenz.

Bellevue Life Sciences Warrant

NASDAQ · OSRHW
$0.06+0.00(+0.00%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Bellevue Life Sciences Warrant's future dividend policy...
Alpha Chat Insight

Bellevue Life Sciences Warrant's ROE is -50.6%. Explore profitability and growth together.

Ask for details

Company Overview

Bellevue Life Sciences Warrant is a financial derivative instrument that provides the holder with the right, but not the obligation, to purchase a specified amount of shares of the underlying Bellevue Life Sciences asset at a predetermined price before the expiration date. Warrants like these are typically leveraged tools offering exposure to the company's growth potential, especially attractive in the life sciences sector known for volatile and rapid advancements. Key industries impacted by Bellevue Life Sciences include biotechnology, pharmaceuticals, and healthcare, where innovation drives value. Warrants offer investors strategic opportunities to participate in the underlying asset's future price movements, making them significant in speculative or long-term strategic investment strategies. Due to their inherent leverage, the value and market significance of warrants like Bellevue's are closely tied to the performance and developments within the life sciences sector, which remains a critical area for research and development globally.

CEOMr. Kuk Hyoun Hwang
SectorHealthcare
IndustryBiotechnology
Employees19

Company Statistics

FY 2025

Profile

N/AMarket Cap
$2.91MRevenue
0.00Shares Out
19Employees

Margins

20.40%Gross
-656.48%EBITDA
-631.01%Operating
-994.16%Pre-Tax
-931.19%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

N/ARev 3Yr
N/ARev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-31.18%ROA
-50.63%ROE
-32.71%ROIC

Financial Health

$1.70MCash & Cash Equivalents
$42.50MNet Debt
34.79%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Bellevue Life Sciences Warrant (ticker: OSRHW) is a company listed on NASDAQ in the Healthcare sector (Biotechnology). It has approximately 19 employees.

The current price is $0.056 with a P/E ratio of -x and P/B of -x.

ROE is -50.63% and operating margin is -631.01%. Annual revenue is $3M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Bellevue Life Sciences Warrant (OSRHW) Stock Forecast 2026 $0.06 — Price, Financials & Analyst Targets | Alpha Lenz